GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹11,813 Cr | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr | ₹10,641 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹11,813 Cr |
| Mar2024 | ₹11,583 Cr |
| Mar2023 | ₹12,305 Cr |
| Mar2022 | ₹10,944 Cr |
| Mar2021 | ₹10,641 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,813 Cr | 1.98 | |
| Mar2024 | ₹11,583 Cr | -5.86 | |
| Mar2023 | ₹12,305 Cr | 12.44 | |
| Mar2022 | ₹10,944 Cr | 2.85 | |
| Mar2021 | ₹10,641 Cr | - | |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,694.6 Cr | -2.8% | -8.4% | 32.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.8% |
-8.4% |
32.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses